Genetic Modifiers of Cystic Fibrosis Related Diabetes
NCT01113216 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2026-04-13
Summary
This research is being done to find the genes and other factors that are responsible for differences among persons with cystic fibrosis. We are particularly interested in the factors that relate to the development of Cystic Fibrosis Related Diabetes (CFRD).
Conditions
- Cystic Fibrosis Related Diabetes
Sponsors & Collaborators
-
Cystic Fibrosis Foundation
collaborator OTHER -
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH - collaborator OTHER
- collaborator OTHER
- lead OTHER
Principal Investigators
-
Scott M Blackman, MD, PhD · Johns Hopkins University
Eligibility
- Min Age
- 3 Months
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2030-04-30
- Completion
- 2030-04-30
Countries
- United States
Study Locations
More Related Trials
-
Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
NCT06163482 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease
NCT00804583 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
Genetic Modifiers of Cystic Fibrosis: Sibling Study
NCT00037778 ·Status: COMPLETED
-
Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)
NCT07102043 ·Status: NOT_YET_RECRUITING
-
Gene Modifiers of Cystic Fibrosis Lung Disease
NCT00037765 ·Status: ACTIVE_NOT_RECRUITING
-
Development of Diabetes in Adults With Cystic Fibrosis (CF)
NCT03644199 ·Status: WITHDRAWN ·Phase: NA
-
Pulmonary Vascular Disease in CF
NCT04549077 ·Status: ACTIVE_NOT_RECRUITING
-
Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)
NCT00082238 ·Status: COMPLETED ·Phase: NA
-
Prevention of Cystic Fibrosis Diabetes
NCT00967798 ·Status: TERMINATED ·Phase: PHASE3
-
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
NCT01805713 ·Status: COMPLETED
-
The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic Fibrosis
NCT02810691 ·Status: COMPLETED ·Phase: NA
-
Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis
NCT05099939 ·Status: RECRUITING
-
GERD in Children With Cystic Fibrosis
NCT06617013 ·Status: RECRUITING ·Phase: NA
-
Redox Imbalance and the Development of Cystic Fibrosis Diabetes
NCT02202876 ·Status: COMPLETED ·Phase: NA
-
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
NCT04568980 ·Status: COMPLETED
-
Glycemic Monitoring in Cystic Fibrosis
NCT02211235 ·Status: COMPLETED
-
FEED-Cystic Fibrosis (FEED-CF)
NCT05766774 ·Status: RECRUITING ·Phase: NA
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
NCT06350149 ·Status: RECRUITING ·Phase: NA
-
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
NCT02477319 ·Status: COMPLETED
-
Diabetes Therapy to Improve BMI and Lung Function in CF
NCT00072904 ·Status: COMPLETED ·Phase: PHASE3
-
Early Intervention in Cystic Fibrosis Exacerbation
NCT01104402 ·Status: COMPLETED ·Phase: NA
-
Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis
NCT05229640 ·Status: WITHDRAWN ·Phase: NA
-
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
NCT01851694 ·Status: RECRUITING ·Phase: NA
-
β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis
NCT04379726 ·Status: UNKNOWN